News
The report covers 40+ companies and 50+ pipeline drugs. Explore drug profiles from clinical to nonclinical stages, assessment by product type, and de ...
Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...
The Health ATM, inspired by the central government’s e-Sanjeevani National Telemedicine Service, is claimed to perform up to ...
Kent Imaging is excited to announce a software update to SnapshotNIR. The emphasis is on documentation, with new report ...
Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...
“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...
Introduction: Development of hemoglobin-based oxygen carriers (HBOCs) for use as temporary blood replacement solutions and treatment of hemorrhagic shock has been hindered because of evidence HBOC ...
R.E.P.O. "I Love" refers to a series of animation memes based on a viral video of R.E.P.O player Just_CSmallz singing "Chest Pain (I Love)" by Malcolm Todd while rolling on the ground during a stream ...
SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients ...
Sprains and strains are common musculoskeletal injuries that can cause significant pain, swelling, and impaired joint movement. However, sprains differ in that they involve the stretching or tearing ...
Patients receiving Cresp showed a mean hemoglobin increase of 2.28 g/dL from baseline i.e. from 8.56 g/dL to 10.84 g/dL, showing strong efficacy in anemia correction. The benefit was noted across ...
Institute of Laser and Optoelectronics Technology, Fujian Provincial Key Laboratory for Photonics Technology, Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results